Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To estimate antitumor activity of abiraterone acetate, as measured by the 6 months clinical benefit rate (CBR) in molecular apocrine HER2-negative locally advanced or metastatic breast cancer.
Inclusion criteria
- Molecular apocrine locally advanced or metastatic breast cancer